NYSE:MDTMedical Equipment
How Investors Are Reacting To Medtronic (MDT) Launching a Global Heart Failure Clinical Trial
Earlier this month, Medtronic announced the launch of the pivotal ELEVATE-HFpEF global clinical trial studying elevated and personalized cardiac pacing rates as a potential treatment for patients with heart failure with preserved ejection fraction, a condition with significant unmet medical need.
This research could position Medtronic to expand the use of its pacemaker technology into an underserved patient population as the global prevalence of HFpEF continues to rise.
We'll examine how...